ValuEngine Downgrades ESSA Pharma (NASDAQ:EPIX) to Hold

Share on StockTwits

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, ValuEngine reports.

A number of other brokerages also recently commented on EPIX. Zacks Investment Research upgraded shares of ESSA Pharma from a “sell” rating to a “buy” rating and set a $2.50 price objective for the company in a research report on Wednesday, May 22nd. HC Wainwright restated a “buy” rating on shares of ESSA Pharma in a research report on Friday, May 17th.

ESSA Pharma stock traded up $0.05 during trading hours on Tuesday, reaching $2.82. 11,180 shares of the stock were exchanged, compared to its average volume of 16,424. The stock has a market cap of $22.38 million, a P/E ratio of -1.11 and a beta of 1.85. The company has a debt-to-equity ratio of 2.27, a quick ratio of 1.06 and a current ratio of 1.06. ESSA Pharma has a 52-week low of $1.41 and a 52-week high of $4.50. The firm’s 50 day moving average is $2.21 and its 200 day moving average is $2.63.

ESSA Pharma Company Profile

ESSA Pharma Inc, a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

See Also: What is the NASDAQ Stock Market?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

ValuEngine Downgrades ESSA Pharma  to Hold
ValuEngine Downgrades ESSA Pharma to Hold
Finjan Holdings Inc  Given Consensus Recommendation of “Strong Buy” by Brokerages
Finjan Holdings Inc Given Consensus Recommendation of “Strong Buy” by Brokerages
Allianzgi NFJ Dividend int & Prm Stgy Fd  Plans Quarterly Dividend of $0.23
Allianzgi NFJ Dividend int & Prm Stgy Fd Plans Quarterly Dividend of $0.23
3D Systems  Rating Increased to Strong-Buy at ValuEngine
3D Systems Rating Increased to Strong-Buy at ValuEngine
Sprott Focus Trust  to Issue — Dividend of $0.11
Sprott Focus Trust to Issue — Dividend of $0.11
Allegion PLC  to Issue $0.27 Quarterly Dividend
Allegion PLC to Issue $0.27 Quarterly Dividend


© 2006-2019 Ticker Report